Enter your terms above and click the 'Search' button.

Showing articles 0 to 2 of 2 Filter Applied: amyloid-related imaging abnormalities (Click to remove) Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021 Lecanemab in Early Alzheimers Disease NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023 Showing articles 0 to 2 of 2